SCHEMBL21749357

SCHEMBL21749357

CC(C)c1cc(C(=O)c2c(Cl)cc(N3C(=O)c4ccccc4C3=O)cc2Cl)nn(C)c1=O

nearest known ligand 0.52

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
THRB P10828 5/20 0.52
THRA P10827 4/20 0.50
GRM1 Q13255 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
DPP4 P27487 1/20 0.34
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
USP2 O75604 1/20 0.34
TSHR P16473 1/20 0.34
PLA2G1B P04054 1/20 0.34
ATG4B Q9Y4P1 1/20 0.34
GRM4 Q14833 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21749474 0.81 THRB (0.38) THRBTHRA
SCHEMBL21749554 0.79 THRB (0.59) THRBTHRA
SCHEMBL38650643 0.77 THRA (0.55) THRBTHRAKMT2AMEN1DPP4
SCHEMBL38650600 0.77 KMT2A (0.35) THRBTHRAKMT2AMEN1DPP4
SCHEMBL2927692 0.77 THRA (0.55) THRBTHRAKMT2AMEN1DPP4
SCHEMBL2928500 0.77 THRA (0.58) THRBTHRA
SCHEMBL30820666 0.77 THRA (0.58) THRBTHRA
SCHEMBL13116456 0.77 KMT2A (0.35) THRBTHRAKMT2AMEN1DPP4
SCHEMBL28560601 0.77 THRB (0.56) THRBTHRA
SCHEMBL28912595 0.75 THRB (0.54) THRBTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112805005-B Thyroxine receptor beta agonist compounds 拓臻股份有限公司 2026-05-12 CN disclosed
EP-3840755-B1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS TERNS INC (US) 2026-02-18 EP disclosed
US-20250236615-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. 2025-07-24 US disclosed
US-20220348561-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS TERNS PHARMACEUTICALS INC (US) 2022-11-03 US disclosed
US-11203587-B2 Thyroid hormone receptor beta agonist compounds Terns, Inc. (US) 2021-12-21 US disclosed
US-11203587-B2 Thyroid hormone receptor beta agonist compounds Terns, Inc. (US) 2021-12-21 US disclosed
EP-3863635-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. (US) 2021-08-18 EP disclosed
EP-3840755-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. (US) 2021-06-30 EP disclosed
CN-112805005-A Thyroxine receptor beta agonist compounds 拓臻股份有限公司 2021-05-14 CN disclosed
US-10800767-B2 Thyroid hormone receptor beta agonist compounds Terns, Inc. (US) 2020-10-13 US disclosed
US-10800767-B2 Thyroid hormone receptor beta agonist compounds Terns, Inc. (US) 2020-10-13 US disclosed
US-20200115362-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS TERNS PHARMACEUTICALS, INC. (KY) 2020-04-16 US disclosed
US-20200115362-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS TERNS PHARMACEUTICALS, INC. (KY) 2020-04-16 US disclosed
WO-2020041741-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. (US) 2020-02-27 WO disclosed
US-20200062742-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. 2020-02-27 US disclosed
US-20200062742-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. 2020-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200062742-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS THRB, THRA, TSHR THRB 1/4885THRA 2/4885GRM1 357/4885
US-20220348561-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS THRB, THRA, TSHR THRB 1/4885THRA 2/4885GRM1 349/4885
US-20200115362-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS THRB, THRA, TSHR THRB 1/4885THRA 2/4885GRM1 349/4885
US-20250236615-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS THRB, THRA, TSHR THRB 1/4885THRA 2/4885GRM1 357/4885
US-11203587-B2 Thyroid hormone receptor beta agonist compounds THRB, THRA, TSHR THRB 1/4885THRA 2/4885GRM1 349/4885
US-10800767-B2 Thyroid hormone receptor beta agonist compounds THRB, THRA, TSHR THRB 1/4885THRA 2/4885GRM1 357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.